Cellipont Bioservices announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas.
The achievement is especially significant given that Cellipont initiated GMP manufacturing operations at the facility in June 2025. Reaching 100 GMP batch releases in approximately one year reflects the strength of the company's operational infrastructure, the growing demand from its clients, and the dedication of its cross-functional teams.
"We are incredibly proud of the Cellipont team and what they have accomplished in such a short period of time," said Darren Head, CEO of Cellipont Bioservices. "Reaching our 100th GMP batch release approximately one year after beginning manufacturing operations is an impressive achievement and a testament to the expertise, collaboration, and commitment our employees bring to every client program."
The milestone reflects contributions across Manufacturing, Quality, Supply Chain, Manufacturing Science and Technology, Facilities, Validation, and every supporting function. Together, these teams have delivered GMP batches while maintaining rigorous quality standards and supporting critical client timelines.
"Every batch represents the trust our clients place in Cellipont and our shared responsibility to help advance potentially life-changing cell therapies," added Head. "This milestone belongs to our entire team, and we are proud to celebrate what they have achieved while continuing to build for the future."